| Synthesis and structure–activity relationships of 4-pyridones as potential antimalarials CL Yeates, JF Batchelor, EC Capon, NJ Cheesman, M Fry, AT Hudson, ... Journal of medicinal chemistry 51 (9), 2845-2852, 2008 | 154 | 2008 |
| Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series JM Coteron, D Catterick, J Castro, MJ Chaparro, B Díaz, E Fernández, ... Journal of Medicinal Chemistry 53 (16), 6129-6152, 2010 | 123 | 2010 |
| Economic growth: theory and numerical solution methods A Novales, E Fernández, J Ruíz Springer, 2009 | 113 | 2009 |
| An invitation to open innovation in malaria drug discovery: 47 quality starting points from the TCAMS F Calderón, D Barros, JM Bueno, JM Coterón, E Fernández, FJ Gamo, ... ACS Medicinal Chemistry Letters 2 (10), 741-746, 2011 | 91 | 2011 |
| Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 8. Computational Simulation of Ligand−Receptor Interaction of 5-HT1AR Agonists with … ML López-Rodríguez, MJ Morcillo, E Fernández, B Benhamú, I Tejada, ... Journal of medicinal chemistry 48 (7), 2548-2558, 2005 | 85 | 2005 |
| Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 5. Study of the Physicochemical Influence of the Pharmacophore on 5-HT1A/α1-Adrenergic Receptor … ML López-Rodríguez, MJ Morcillo, E Fernández, E Porras, L Orensanz, ... Journal of medicinal chemistry 44 (2), 186-197, 2001 | 83 | 2001 |
| Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 6. Study of the 5-HT1A/α1-Adrenergic Receptor Affinity by Classical Hansch … ML López-Rodríguez, MJ Morcillo, E Fernández, ML Rosado, L Pardo, ... Journal of medicinal chemistry 44 (2), 198-207, 2001 | 82 | 2001 |
| Synthesis and Structure− Activity Relationships of a New Model of Arylpiperazines. 4. 1-[ω-(4-Arylpiperazin-1-yl) alkyl]-3-(diphenylmethylene)-2, 5-pyrrolidinediones and-3-(9 H … ML López-Rodríguez, MJ Morcillo, TK Rovat, E Fernández, B Vicente, ... Journal of medicinal chemistry 42 (1), 36-49, 1999 | 76 | 1999 |
| Synthesis and structure− activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure− activity relationships of hydantoin … ML López-Rodríguez, ML Rosado, B Benhamú, MJ Morcillo, E Fernández, ... Journal of medicinal chemistry 40 (11), 1648-1656, 1997 | 71 | 1997 |
| Structural insights into PROTAC-mediated degradation of Bcl-xL C Chung, H Dai, E Fernandez, CP Tinworth, I Churcher, J Cryan, ... ACS Chemical Biology 15 (9), 2316-2323, 2020 | 60 | 2020 |
| Substituted 1-[(benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo R Whomsley, E Fernandez, PJ Nicholls, HJ Smith, P Lombardi, ... The Journal of Steroid Biochemistry and Molecular Biology 44 (4-6), 675-676, 1993 | 56 | 1993 |
| Optimal green tax reforms yielding double dividend E Fernández, R Pérez, J Ruiz Energy Policy 39 (7), 4253-4263, 2011 | 47 | 2011 |
| Synthesis and Structure− Activity Relationships of a New Model of Arylpiperazines. 3. 2-[ω-(4-Arylpiperazin-1-yl) alkyl] perhydropyrrolo-[1, 2-c] imidazoles and-perhydroimidazo … ML López-Rodríguez, MJ Morcillo, E Fernández, E Porras, M Murcia, ... Journal of medicinal chemistry 40 (16), 2653-2656, 1997 | 44 | 1997 |
| Indeterminacy under non-separability of public consumption and leisure in the utility function E Fernández, A Novales, J Ruiz Economic Modelling 21 (3), 409-428, 2004 | 43 | 2004 |
| A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery MB Jiménez-Díaz, S Viera, J Ibanez, T Mulet, N Magan-Marchal, H Garuti, ... PloS one 8 (6), e66967, 2013 | 41 | 2013 |
| Cyclopropyl carboxamides: a new oral antimalarial series derived from the Tres Cantos anti-malarial set (TCAMS) L Rueda, I Castellote, J Castro-Pichel, MJ Chaparro, JC de la Rosa, ... ACS Medicinal Chemistry Letters 2 (11), 840-844, 2011 | 38 | 2011 |
| The environmental Kuznets curve and equilibrium indeterminacy E Fernández, R Pérez, J Ruiz Journal of Economic Dynamics and Control 36 (11), 1700-1717, 2012 | 31 | 2012 |
| Design and synthesis of S-(−)-2-[[4-(napht-1-yl) piperazin-1-yl] methyl]-1, 4-dioxoperhydropyrrolo [1, 2-a] pyrazine (CSP-2503) using computational simulation. A 5-HT1A … ML López-Rodrı́guez, MJ Morcillo, E Fernández, B Benhamú, I Tejada, ... Bioorganic & medicinal chemistry letters 13 (8), 1429-1432, 2003 | 26 | 2003 |
| A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold F Calderón, J Vidal-Mas, J Burrows, JC de la Rosa, MB Jiménez-Díaz, ... ACS Medicinal Chemistry Letters 3 (5), 373-377, 2012 | 23 | 2012 |
| Tratamiento endovascular y trombólisis intraarterial en el ictus isquémico agudo D Escudero, R Molina, L Viña, P Rodríguez, L Marqués, E Fernández, ... Medicina intensiva 34 (6), 370-378, 2010 | 20 | 2010 |
JESUS RUIZ ANDUJARUniversidad Complutense de MadridVerified email at ucm.es
